MENU

ANTX AN2 Therapeutics Forecast, Technical & Fundamental Analysis

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform... Show more

ANTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ANTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ANTX is expected to report earnings to fall 20.69% to -23 cents per share on August 06

AN2 Therapeutics ANTX Stock Earnings Reports
Q2'26
Est.
$-0.23
Q1'26
Missed
by $0.06
Q4'25
Missed
by $0.07
Q3'25
Est.
$-0.31
Q2'25
Beat
by $0.10
The last earnings report on May 11 showed earnings per share of -28 cents, missing the estimate of -23 cents. With 192.71K shares outstanding, the current market capitalization sits at 170.72M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
Managed Health Care
Address
1300 El Camino Real
Phone
+1 650 331-9090
Employees
21
Web
https://www.an2therapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MVTRX10.700.14
+1.33%
Transamerica Mid Cap Value Opps R6
MGLLX17.650.17
+0.97%
MFS Global Real Estate R3
NRILX16.240.14
+0.87%
Neuberger International Sel R6
ECASX23.520.11
+0.47%
Eaton Vance Atlanta Capital SMID-Cap C
SHXPX15.49N/A
N/A
American Beacon Shapiro Equity Opps Inv

ANTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANTX has been loosely correlated with XENE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ANTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANTX
1D Price
Change %
ANTX100%
+6.52%
XENE - ANTX
45%
Loosely correlated
-0.17%
PASG - ANTX
31%
Poorly correlated
+3.75%
SLDB - ANTX
30%
Poorly correlated
-1.11%
DNTH - ANTX
29%
Poorly correlated
+7.35%
EDSA - ANTX
29%
Poorly correlated
+2.65%
More
AN2 Therapeutics (ANTX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com